SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001557142-21-000003
Filing Date
2021-01-12
Accepted
2021-01-12 16:16:06
Documents
12
Period of Report
2021-01-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K kdmn-20210112x8k.htm   iXBRL 8-K 76521
  Complete submission text file 0001557142-21-000003.txt   199782

Data Files

Seq Description Document Type Size
2 EX-101.SCH kdmn-20210112.xsd EX-101.SCH 3071
3 EX-101.LAB kdmn-20210112_lab.xml EX-101.LAB 15502
4 EX-101.PRE kdmn-20210112_pre.xml EX-101.PRE 11475
5 EXTRACTED XBRL INSTANCE DOCUMENT kdmn-20210112x8k_htm.xml XML 4813
Mailing Address 450 EAST 29TH STREET NEW YORK NY 10016
Business Address 450 EAST 29TH STREET NEW YORK NY 10016 212-308-6000
Kadmon Holdings, Inc. (Filer) CIK: 0001557142 (see all company filings)

IRS No.: 273576929 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37841 | Film No.: 21523669
SIC: 2834 Pharmaceutical Preparations